non-pharmaceutical treatment

非药物治疗
  • 文章类型: Journal Article
    谵妄,老年手术患者的常见并发症,围手术期护理面临重大挑战。围手术期老年服务(PGS)旨在管理合并症,术后并发症,并启动早期运动恢复,以提高围手术期老年患者的预后。研究表明,术前认知障碍患者术后谵妄的风险明显增加。虽然术后谵妄影响了高达70%的60岁以上的人和90%的神经退行性疾病患者,在许多情况下,它仍然未被诊断。术后谵妄可导致功能下降,住院时间延长,医疗费用增加,认知障碍,和心理不适。本文简要总结了关于谵妄的文献,其风险因素,以及围手术期的非药物管理策略。它强调了将认知和心理评估纳入围手术期护理方案以提供基线数据的重要性。改善患者预后,减少住院时间,减少与谵妄相关的并发症。通过采用基于证据的谵妄管理方案,医疗保健专业人员可以更好地识别和管理谵妄,最终提高老年手术患者的护理质量,这也将使医护人员和医疗机构受益。
    Delirium, a common complication in elderly surgical patients, poses significant challenges in perioperative care. Perioperative geriatric services (PGS) aim at managing comorbidities, postoperative complications, and initiating early recovery of mobility to enhance elderly patients\' prognosis in the perioperative period. Studies have shown that patients with preoperative cognitive disorders are at a significantly increased risk of postoperative delirium. While postoperative delirium affects up to 70% of people over 60 and 90% of people with neurodegenerative diseases, it remains underdiagnosed in many cases. Postoperative delirium can lead to functional decline, prolonged hospitalization, increased healthcare costs, cognitive impairment, and psychological malaise. This article briefly summarizes the literature on delirium, its risk factors, and its non-pharmaceutical management strategies within the perioperative period. It highlights the importance of integrating cognitive and psychological assessments into perioperative care protocols to provide baseline data, improve patient outcomes, reduce hospital stays, and minimize complications associated with delirium. By embracing evidence-based delirium management protocols, healthcare professionals can better identify and manage delirium, ultimately improving the quality of care for elderly surgical patients, which would also benefit healthcare staff and healthcare institutions.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    在中国农村,高血压患者的治疗依从性仍然是一个挑战.尽管早期关于患者依从性的研究已经证实了信任医生的重要性,信任的二维结构对坚持的相对贡献和影响尚未探讨。因此,这项研究检查了患者对初级保健医生(PCPs)的信任和能力对药物依从性的影响,饮食管理,和身体活动。数据来自2017年2月至2018年5月中国54个基层医疗机构(村级)的2,533名患者。使用中文版的WakeForest医师信任量表和高血压患者的治疗依从性量表对参与者进行评估。其他信息包括地区,性别,年龄,和自我评估的健康状况。多元线性回归和结构方程模型的结果证实,患者对PCPs的信任与患者对药物的依从性呈正相关,饮食管理,和身体活动。患者对PCPs能力的信任与坚持饮食管理和体力活动呈负相关。我们得出的结论是,旨在提高PCP仁慈度的干预措施具有最大的潜力,可以提高患者对高血压治疗的依从性。在国家倡导改善PCP诊断和治疗技术的政策下,培养医生的沟通技巧可能很重要,医学伦理学,和其他仁慈的品质,以提高患者对药物和非药物治疗的依从性。
    In rural China, treatment adherence of patients with hypertension remains a challenge. Although early research on patient adherence has confirmed the importance of trust in doctors, the relative contribution and influence of the two-dimensional structure of trust on adherence has not been explored. Thus, this study examined the effects of patient trust in primary care physicians\' (PCPs) benevolence and ability on medication adherence, dietary management, and physical activity. The data were derived from 2,533 patients at 54 primary health institutions in China (village level) from February 2017 to May 2018. Participants were assessed using the Chinese version of the Wake Forest Physician Trust Scale and the Therapeutic Adherence Subscale for Hypertensive Patients. Other information included region, gender, age, and self-rated health status. The results of multiple linear regression and structural equation modeling confirmed that patient trust in PCPs\' benevolence was positively correlated with patient adherence to medication, diet management, and physical activity. Patient trust in PCPs\' ability was negatively correlated with adherence to dietary management and physical activity. We concluded that interventions aimed at increasing PCP benevolence have the greatest potential to improve patient adherence to hypertension treatment. Under the country\'s policy of advocating to improve PCPs\' diagnoses and treatment technology, it may be important to cultivate doctors\' communication skills, medical ethics, and other benevolent qualities to improve patients\' adherence with drug and Non-drug treatments.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Clinical Trial
    与糖尿病性周围神经病变(DPN)症状的常规治疗相关的不令人满意的结果表明,需要研究替代疗法。这项研究的目的是确定全身振动疗法(WBV)作为治疗与DPN相关的疼痛的疗效。患有疼痛性DPN的参与者(n=8)每周接受三次治疗,持续四周。每个疗程包括4次3分钟的振动(频率25赫兹,振幅5毫米)。主要结果指标是视觉模拟疼痛量表(VAS)的变化和神经性疼痛量表(NPS)的变化。WBV在VAS中显示出显着(p<0.05)的急性疼痛减轻,VAS和NPS量表均显著慢性降低。在这项研究中没有观察到副作用。WBV似乎是有效的,DPN相关疼痛的非侵入性治疗。
    The unsatisfactory results associated with conventional treatments for symptoms of diabetic peripheral neuropathy (DPN) demonstrate a need for research into alternative therapies. The purpose of this study was to determine the efficacy of whole body vibration therapy (WBV) as a treatment for pain associated with DPN. Participants (n = 8) with painful DPN received three treatment sessions per week for four weeks. Each session consisted of four bouts of 3 min of vibration (frequency 25 Hz, amplitude 5 mm). The primary outcome measures were changes in the visual analog pain scale (VAS) and changes in the neuropathic pain scale (NPS). WBV demonstrated a significant (p < 0.05) acute pain reduction in the VAS, and a significant chronic reduction in both the VAS and NPS scales. No side-effects were observed during this study. WBV appears to be an effective, non-invasive treatment for pain associated with DPN.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

公众号